/
 TAKAYASU  ARTERITIS  DR.VIGNESH SUKUMAR  TAKAYASU  ARTERITIS  DR.VIGNESH SUKUMAR

TAKAYASU ARTERITIS DR.VIGNESH SUKUMAR - PowerPoint Presentation

test
test . @test
Follow
359 views
Uploaded On 2020-04-04

TAKAYASU ARTERITIS DR.VIGNESH SUKUMAR - PPT Presentation

1908 TAKAYASU FIRST CASE REPORT ONISHI PULSELESSNESS 27 OCT 1939 DEPT OF PSYCHIATRY TOKYO DEATH DUE TO HF AUTOPSY PANARTERITIS OF AORTA BL CCA AND LT SCA FROVIG CASE REPORT OF WOMAN WITH BL CAROTID PULSE OBLITERATION ID: 775383

aorta artery aortic takayasu aorta artery aortic takayasu disease involvement arch lesion active criteria pulmonary activity stenosis arteritis coronary

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document " TAKAYASU ARTERITIS DR.VIGNESH SUKUMAR" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

TAKAYASU ARTERITIS

DR.VIGNESH SUKUMAR

Slide2

Slide3

1908 - TAKAYASU FIRST CASE REPORTONISHI - PULSELESSNESS27 OCT 1939 - DEPT OF PSYCHIATRY, TOKYO - DEATH DUE TO HF – AUTOPSY – PANARTERITIS OF AORTA, B/L CCA AND LT SCAFROVIG - CASE REPORT OF WOMAN WITH B/L CAROTID PULSE OBLITERATION

HISTORY

Slide4

ROSS & MCKUSICK- 100 CASES –AORTIC ARCH SYNDROME- YOUNG FEMALE ARTERITIS1963-HIDEO UEDA- MANY CASE STUDIES – AORTA AND MAIN BR, CORONARY & PULMONARY ARTERY – PANAORTITIS  AORTITIS SYNDROME – PROBABLE AUTOIMMUNE CAUSE1975- DEPT OF HEALTH & WELFARE, JAPAN – 1ST COINED - TAKAYASU ARTERITIS

HISTORY

Slide5

AGE OF ONSET < 40CLAUDICATION OF EXTREMETIESDECREASED BRACHIAL ARTERY PULSEBLOOD PRESSURE DIFFERENCE >10MMHG BETWEEN ARMSBRUIT OVER SUBCLAVIAN ARTERY OR AORTAARTERIOGRAM ABNORMALITY- OCCLUSION OR NARROWING OF AORTA OR MAIN BRANCHES

1990 ACR CLASSIFICATION CRITERIA:- 3/6

Slide6

OBLIGATORY CRITERIAAGE <40 AT DIAGNOSIS OR DISEASE ONSETMAJOR CRITERIAINVOLVEMENT OF LEFT SUBCLAVIANINVOLVEMENT OF RIGHT SUBCLAVIANMINOR CRITERIAHIGH ESR, CAROTIDYNIA, HYPERTENSION, AORTIC REGURGITATION OR ANNULO AORTIC ECTASIA, LESIONS OF PULMONARY ARTERY, LEFT MID CCA, DISTAL BRACHIOCEPHALIC TRUNK, THORACIC AORTA AND ABDOMINAL AORTAOBLIGATORY CRITERIA PLUS 2 MAJOR OR ONE MAJOR PLUS 2 OR MORE MINOR, OR 4 OR MORE MINOR

ISHIKAWA CRITERIA

Slide7

REMOVAL OF OBLIGATORY AGE CRITERIAADDITION OF CORONARY ARTERY LESION IN ABSENCE OF RISK FACTORSREMOVAL OF AGE IN DEFINING HYPERTENSION (PREV <40YRS)

SHARMA MODIFIED CRITERIA- 1995

Slide8

MAJOR CRITERIALEFT MIDSUBCLAVIAN ARTERY LESIONRIGHT MID SUBCLAVIAN ARTERY LESIONCHARACTERISTIC SYMPTOMS AND SIGNS FOR >1MONTHLIMB CLAUDICATIONPULSELESSNESS OR BP DIFF >10MMHG IN ARMSEXERCISE ISCHAEMIANECK PAINFEVERAMAUROSIS FUGAXSYNCOPEDYSPNOEAPALPITATIONSBLURRED VISION

SHARMA MODIFIED CRITERIA

Slide9

HIGH ESR >20MM/HR WESTERGREN`SCAROTIDYNIAHYPERTENSION BRACHIAL BP >140/90 POPLITEAL BP >160/90AR OR ANULOAORTIC ECTASIA BY AUSCULTATION OR ECHO OR ARTERIOGRAPHYPA LESION: LOBAR OR SEGMENTAL OCCLUSION OR STENOSIS OR ANEURYSM OF MAIN PTLEFT MIDDLE CCA LESION: STENOSIS OR OCCUSION OF MIDDLE 5 CM STARTING 2CM FROM ORIFICEDISTAL INNOMINATE ART LESION: STENOSIS OR OCCLUSION OF DISTAL 3RDDTA LESION: NARROWING ANEURYSM OR LUMINAL IRREGULARITYABD AORTA LESION: NARROWING ANEURYSM OR LUMINAL IRREGULARITYCORONARY ART LESION : DOCUMENTED BY CAG IN PTS <30YRS AND WITHOUT RISK FACTORS FOR ATHEROSCLEROSIS

MINOR CRITERIA

Slide10

CRITERIASENSITIVITYSPECIFICITYISHIKAWA60.495ACR CRITERIA77.495SHARMA ET AL92.595

IAS- 60,80,90

Slide11

PRE PULSELESS PHASE OF DISEASECONSTITUTIONAL SYMPTOMS – FEVER MYALGIA, WEIGHT LOSS, ARTHRALGIA, HEADACHEPULSELESS PHASE OR LATE OCCLUSIVE PHASEVASCULAR INSUFFICIENCYDIMINISHED OR ABSENT PULSESBRUITSHYPERTENSIONRENAL ARTERY STENOSISAORTIC REGURGITATION AND HEART FAILURE

TWO STAGE PROCESS

Slide12

USUALLY CAUSES WALL EROSION AND FORMATION OF FALSE OR TRUE ANEURYSMSCOMBINATION OF STENOSIS AND ANEURYSM IS RARE IN TB ARTERITISPREDOMINANTLY INVOLVES DESC THO AORTA AND ABDOMINAL AORTA. ASCENDING AORTA IS USUALLY SPARED IN TB ARTERITISRENAL ARTERY INVOLVEMENT IS RAREDISSECTION AND RUPTURE OF ANEURYSMS ARE MC IN TB ARTERITS WHICH IS DISTINCTLY UNCOMMON IN TAKAYASU`S

TB ARTERITIS ???

Slide13

LUPI HERERA ET AL48% OF JAPANESE PTS WERE FOUND TO HAVE TUBERCULOSISSEN ET AL71% OF INDIAN PTS WERE FOUND TO HAVE CO EXISTING TUBERCULOSISSUBRAMANYAN ET AL (SCTIMST)(16/88)18.2% HAD SKIN TEST +VE AND WERE GVEN ATTONLY 3 HAD ACTIVE PULMONARY DISEASE

Slide14

PRESENTS AT AN OLDER AGEOFTEN INVOLVES ASCENDING AORTADTA IS SPAREDSTENOSIS OF AORTA AND LARGE ARTERIES ARE NOT A FEATURE OF LEUTIC AORTITS

LEUTIC AORTITIS ???

Slide15

TYPESARTERIAL INVOLVEMENT1BRANCHES OF AORTIC ARCH2AASCENDING AORTA, AORTIC ARCH AND BRANCHES2BASCENDING AORTA, AORTIC ARCH AND BRANCHES, AND DESCENDING THORACIC AORTA3DESCENDING THORACIC AORTA ABDOMINAL AORTA AND RENAL ARTERIES4ONLY ABDOMINAL AORTA AND RENAL ARTERIES5COMBINED 2B AND 4

ANGIOGRAPHIC CLASSIFICATION OF TA

TAKAYASU CONFERENCE 1994

Slide16

Slide17

1.AORTIC ARCH VARIETYANY 1 OF THE 3 INVOLVED2.THORACO ABDOMINAL VARIETYDTA AND AA OR ITS BRANCHES3.COMBINED VARIETYBOTH ARCH AND THORACOABDOMINAL VARIETY4.PULMONARY VARIETYPULMONARY ARTERY INVOLVEMENT IN COMBINATION WITH ANY OF THE THREEPANJA ET AL5. CORONARY ARTERY INVOLVEMENT

LUPI HERRERA CLASSIFICATION

Slide18

OCCURS IN <10%OFTEN FATAL3 TYPES1.STENOSIS OR OCCUSION OF OSTIUM2.DIFFUSE OR FOCAL ARTERITIS3.CORONARY ANEURYSMMC IS TYPE 1 – OSTIAL INVOLVEMENT

CORONARY INVOLVEMENT IN TA

Slide19

~70% INVOLVEMENT BY ANGIOGRAPHIC STUDIES( ~36% PANJA ET AL INDIA)SEGMENTAL AND SUBSEGMENTAL BRANCHESMORE IN UPPER LOBEHEMOPTYSISNON ANGINAL CHEST PAINDISPROPORTIONATE PAHOLIGEMIC LUNG FIELDS IN CXR ABNORMAL VENTILATION PERFUSION SCAN

PULMONARY ARTERY INVOLVEMENT

Slide20

~96% FEMALESAORTIC ARCH AND BRANCHES ARE INVOLVED MORE OFTEN (TYPE 1 AND 2A)MORE AORTIC REGURGITATIONPRESENTATION - UL CLAUDICATION AND PULSELESSNESSVASCULITIS INVOLVES ASC-TA AND DSC-TA FORMS MORE COMPLICATED LESIONS AND PROLONGED INFLAMATORY ACTIVITYHLA B52 AND HLA B29

JAPANESE - TA

Slide21

ONLY 63% FEMALESABDOMINAL AORTA AND RENAL ARTERY INVOLVEMENT COMMON (TYPE 4)MC PRESENTATION IS HYPERTENSIONVASCULITIS INVOLVES ABD AORTA AND LOWER INFLAMATORY ACTIVITY LESS COMPLICATED LESIONS AND EXTENSION TO THORACIC AORTA AFTER ONE OR TWO DECADES

INDIAN - TA

Slide22

Slide23

STAGECLINICAL FEATURESSTAGE 1UNCOMPICATED DISEASESTAGE 2AMILD/ MODERATE SINGLE COMPLICATIONSTAGE 2BSEVERE SINGLE COMPLICATIONSTAGE 3TWO OR MORE COMPLICATIONS

ISHIKAWA CLINICAL CLASSIFICATION OF TA

NORMAL OR ELEVATED ESR WITH OR WITHOUT PULMONARY INVOLVEMENT

4 COMPLICATIONS

RETINOPATHY, SECONDARY HTN, AR AND ANEURYSM FORMATION

Slide24

Slide25

ISHIKAWA ET AL SURVIVAL AT 5 YEARS AFTER DIAGNOSIS 83.1%CARDIAC FAILURE - MCC OF DEATHCHILDHOOD ONSET WORSE PROGNOSIS ESP WHEN A/W DCMA FAILED ANGIOPLASTY IMPLICATES HIGH MORTALITY

NATURAL HISTORY

Slide26

88 PTS - MEAN AGE ~24YRS38.6% WERE MEN (HIGHER)AT 10 YRS OVERALL SURVIVAL – 80% EVENT FREE SURVIVAL - 61%GRPS 1 AN 2A HIGHER EVENT FREE SURVIVAL RATE THAN GRPS 2B AND 3PREDICTORS OF DEATH OR MAJOR EVENTSEVERE HYPERTENSION, SEVERE FUNCTIONAL DISABILITY, CARDIAC INOLVEMENT(CARDIOMEGALY, LVH IN ECG AND LV DYSFUNCTION )

SUBRAMANIYAM ET AL

SRI CHITRA

Slide27

ANATOMIC TYPE OF ARTERITIS AND PATHOLOGIC TYPE OF LESION STENOTIC OR ANEURYSMAL DID NOT AFFECT THE EVENT FREE SURVIVAL

Slide28

Slide29

MC MANIFESTATION IS TORTUOSITY AND DILATION OF RETINAL VEINS WITH SLOW BLOOD CIRCULATIONFFA- DELAYED FILLING OF CHOROIDAL AND RETINAL CIRCULATIONSHYPOPERFUSIVEISCHEMIC OCULAR SYNDROMEAION - CRAOHYPERTENSIVEEXUDATIVE RETINOPATHYRETINAL DETATCHMENT PAPILLOEDEMA

OCULAR MANIFESTATIONS

Slide30

HYPERTENSIVE RETINOPATHYKEITH WAGNER CLASSIFICATIONARTERIOLAR NARROWING, AV CROSSING CHANGES, COPPER WIRING, EXUDATES, SILVER WIRING AND PAPILLOEDEMANON HYPERTENSIVE / ISCHAEMIC RETINOPATHY CLASSIFICATIONUYAMA AND ASAYAMA

OCULAR MANIFESTATIONS

Slide31

STAGE 1 – DILATION OF SMALL VESSELSSTAGE 2 – MICROANEURYSM FORMATIONSTAGE 3 – WREATH LIKE ARTERIO VENOUS ANASTAMOSIS SURROUNDING OPTIC PAPILLAESTAGE 4 – CATARACT, SECONDARY GLAUCOMA, NEOVASCULARISATION, PROLIFERATIVE RETINOPATHY, VITREOUS HMGMILD : STAGE 1MODERATE: STAGE 2SEVERE: STAGE 3 AND 4

UYAMA AND ASAYAMA CLASSIFIACTION OF RETINOPATHY

Slide32

CASE REPORT

CMC VELLORE

Slide33

RENO VASCULAR HTNAORTIC REGURGITATIONCAROTID ARTERY STENOSIS (DECREASED PERFUSION TO BARORECEPTORS)THICKENED AND STIFF AORTA

CAUSES OF HYPERTENSION IN TA

GB PANTH, NEW DELHI

Slide34

CMC VELLORE

Slide35

AGE<16YRS - NOT AS FREQUENT AS ADULTSMORE SEVERE MANIFESTATIONSCAN BE A/W MYOCARDITIS AND DCM LIKE PRESENATIONPRESENTING FEATURES – FEVER, HEADACHE, HTN AND HFAN ASOCIATION WITH TUBERCULOSIS POSTULATED BUT NEVER PROVENHIGH RELAPSE RATE - NEEDS AGGRESSIVE IMMUNOSUPPRESSION

CHILDHOOD TAKAYASU [c-TA]

Slide36

PREGNANCY DOES NOT EXACERBATE DISEASEHTN MANAGEMENT IS ESSENTIALMATERNAL COMPLICATIONSPRE ECLAMPSIA, ECLAMPSIA, CHF, PROGRESSIVE RENAL IMPAIRMENTABDOMINAL AORTIC INVOLVEMENT AND DELAY IN SEEKING MEDICAL ATTENTION PREDICTED POOR PERINATAL OUTCOME

PREGNANCY AND TAKAYASU

Slide37

OFTEN BILATERAL & OSTIALBEST TREATED BY PTBAGB PANTH STUDYSUCCESS RATE – 89.3%CHILDREN HAD HIGHER PROPORTION OF RESTENOSISSTENT PLACEMENT FOLLOWING PTBAOSTIAL LESIONSLONG SEGMENT LESIONSINCOMPLETE RELIEF OF STENOSES DISSECTION

RENAL ARTERY INVOLVEMENT

Slide38

ACTIVE DISEASE ???

YES OR NO

Slide39

SYSTEMIC FEATURESFEVER, MUSCULOSKELETAL AND CONSTITUTIONAL SYMPTOMSELEVATED ESRFEATURES OF VASCULAR ISCHAEMIA OR INFLAMMATIONCLAUDICATION, VASCULAR PAIN OR CAROTIDYNIA, DIMINISHED OR ABSENT PULSE, VASCULAR BRUIT, ASSYMMETRIC BP IN BOTH UPPER LIMBSTYPICAL ANGIOGRAPHIC FEATURESNEW ONSET OR WORSENING OF 2 OR MORE FEATURES INDICATE ACTIVE DISEASE

KERR CRITERIA

Slide40

DISEASE EXTENT INDEX FOR TAKAYASU ARTERITIS -2005INDIAN TAKAYASU ACTIVITY SCOREITAS - 2010ITAS – 2010 – AESR CRP0 - <20 0 - <51 - 20-39 1 – 6-102 - 40-59 2 – 11-203 - >60 3 - >20

DEI-TAK & ITAS

Slide41

Slide42

BOTH DEI-TAK AND ITAS DERIVED FROM BVASBIRMINGHAM VASCULITIS ACTIVITY SCALE

Slide43

Slide44

RECENT STUDIESABSENCE OF CONSTITUTIONAL SYMPTOMS AND NORMAL ESR AND CRP DOES NOT RULE OUT ACTIVE DISEASEPREFER IMAGING MODALITIES

Slide45

SEROLOGICAL MARKERS

ARE THEY RELIABLE ???

Slide46

In conclusion, the present results suggest that

monitoring of circulating levels of MMP-2 as a helpful marker in diagnosing TA and those of MMP-3 and MMP-9 as disease activity markers might help provide adequate evaluation of treatment and guide therapeutic decision making for individual patients with TA. These measurements can be part of routine hospital laboratory examinations that are easy to perform at low cost. Furthermore, the noninvasive nature of such measurements is attractive, because patients can be spared from invasive angiographic examination.

Matrix

Metalloproteinases

as Novel Disease Markers in

Takayasu

Arteritis

Slide47

Slide48

MMP-9 PENTRAXIN-3RANTESIL-6MMP 2 IN DIAGNOSING MMP 3 AND 9 IN ASSESSING ACTIVITY

MARKERS OF ACTIVE DISEASE

NOT AFFECTED BY PREDNISOLONE

Slide49

Slide50

Slide51

Slide52

Slide53

Slide54

Slide55

Slide56

Slide57

AORTIC WALL THICKNESS OF

>4MM-

90% SENSITIVITY IN IDENTIFYIN THE INVOLVED ARTERIAL SEGMENT

ACTIVE DISEASE:

INCREASED VESSEL WALL THICKNESS, WALL EDEMA AND MURAL CONTRAST ENHANCEMENT

Slide58

Slide59

TURKISH STUDY- 2013

UPTAKE ON PET - NOT SPECIFIC

DIFF FROM ATHEROSCLEROSIS DIFFICULT

Slide60

GRADE O - LOW GRADE UPTAKEGRADE 1 – UPTAKE PRESENT BUT LOWER THAN LIVERGRADE 2 – UPTAKE SIMILAR TO LIVERGRADE 3 – UPTAKE GREATER THAN LIVER BUT LESSER THAN OR SIMILAR TO CEREBRAL CORTEXGRADE 2 OR MORE IS S/O ACTIVE DISEASE IN TAKAYASU`S

SUV- STANDARDIZED UPTAKE VALUE

Slide61

Slide62

Slide63

REMISSION AND SUSTAINED REMISSION

REMISSION

ABSENCE OF SYMPTOMS

NORMAL INFLAMMATORY MARKERS

NO NEW IMAGING FINDINGS

SUSTAINED REMISSION

REMISSION FOR ATLEAST 6 MONTHS

ON STEROIDS<10MG/DAY

Slide64

ANTI TNF AGENTSETANERCEPTINFLIXIMABANTI CD20RITUXIMABIL-6 ANTAGONISTTOCILZUMAB

BIOLOGICS

Slide65

FRENCH STUDY

Slide66

Slide67

Slide68

Slide69

TURKISH TA PTS HAD AN ASSO WITH HLA B52ESR AND CRP- NO CORRELATION WITH ACTIVITYUSE OF ANTIPLT AGENTS WAS A/W LOWER FREQ OF ISCHEMIC EVENTSIL-6 LEVELS CORRELATED WITH DISEASE ACTIVITY TOCILIZUMAB(IL-6 RECEPTOR ANTAGONIST) HAD PROMISING RESULTS IN REFRACTORY CASESSTENT GRAFTS WERE BETTER THAN UNCOVERED METAL STENTS OR BALOON ANGIOPLASTY

STUDY FROM TURKEY 2013

Slide70

ENDOVASCULAR INTERVENTIONSUBCLAVIAN ANGIOPLASTYAORTOPLASTYRENAL ANGIOPLASTYCAROTID ANGIOPLASTYCORONARY ANGIOPLASTYMESENTRIC ANGIOPLASTYPULMONARY ATERY ANGIOPLASTY

INTERVENTIONS

Slide71

ARTERIAL LUMEN <30% OF RESIDUAL STENOSISARTERIAL LUMEN ATLEAST 50% LARGER THAN PRE TREATMENT DIAMETERGRADIENT <20MMHG OR DECREASED ATLEAST 15MMHG FROM PRE TREATMENT GRADIENT

A SUCCESSFUL ANGIOPASTY

GB PANTH, DELHI

Slide72

~20% REQUIRE SURGERYAORTOCERVICAL BYPASSCERVICO SUBCLAVIAN BYPASSAORTO CORONARY BYPASSAORTO AORTIC BYPASSRENAL ARTERY BYPASSAORTIC ROOT REPLACEMENTNEPHRECTOMY FOR NON-FUNC KIDNEY TO CONTROL HTNCABG LESS PREFERRED

SURGERY

Slide73

NEWER STUDIES

CMC VELLORE

Slide74

Slide75

Slide76

Slide77

(A and C) Baseline angiograms showing diseased arterial segments containing tangles of corkscrew channels located within the expected confines of the vessel wall In the distal right and proximal left common carotid arteries (indicated by black arrows and white arrows, respectively, throughout panels A to F). (B and D) Corresponding images immediately after angioplasty and stenting show replacement of the manifold channels by a single large conduit

Slide78

(E) Baseline aortic arch angiogram showing the diseased common carotid artery segments and bilaterally occluded subclavian arteries (hollow block arrows). (F) Two-year post-intervention follow-up aortic arch angiogram showing patency of carotid and subclavian stents bilaterally.

Slide79

THANK YOU